Health-Related Quality of Life and Support Group Attendance for Patients with Systemic Lupus Erythematosus

Journal of Clinical Rheumatology

Volumn 10, Issue 1, 2004, Pages 6-9

  Dorsey, Rashida R ^a   Andresen, Elena M ^a   Moore, Terry L ^a,b  

^a SAINT LOUIS UNIVERSITY   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmune disease; Lupus; Quality of life; Social support

Indexed keywords

ADULT; AGE; ARTICLE; AUTOIMMUNE DISEASE; CAUCASIAN; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; FITNESS; HUMAN; MAJOR CLINICAL STUDY; MENTAL HEALTH; NEGRO; PRIORITY JOURNAL; QUALITY OF LIFE; SUPPORT GROUP; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 1042279532     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rhu.0000111311.38407.15     Document Type: Article

References (25)

1. Liang MH, Socher SA, Larson MG, et al. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1989;32:1107-1118.
2. Karlson EW, Daltroy LH, Lew RA, et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum. 1997;40:47-56.
3. Thumboo J, Fong K, Chan S, et al. A prospective study of factors affecting quality of life in systemic lupus erythematosus. J Rheumatol. 2000;27:1414-1420.
4. Wang C, Mayo NE, Fortin PR. The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol. 2001;28:525-532.
5. Ginzler EM, Berg A. Mortality in systemic lupus erythematosus. J Rheumatol. 1987;13(suppl):218-222.
6. Swaak AJG, Nossent JC, Smeenk RJT. Prognostic factors in systemic lupus erythematosus. Rheumatol Int. 1991;11:127-132.
7. Fortin PR, Abrahamowicz M, Neville C, et al. Impact of disease activity and cumulative damage on the health of lupus patients. Lupus. 1998;7:101-107.
8. Gladman DD, Urowitz MB, Ong A, et al. Lack of correlation among the 3 outcomes describing SLE: disease activity, damage, and quality of life. Clin Exp Rheumatol. 1996;14:305-308.
9. Gladman D, Urowitz M, Ong A, et al. A comparison of 5 health status instruments in patients with systemic lupus erythematosus. Lupus. 1996;5:190-195.
10. Dobkin PL, Da Costa D, Drista M, et al. Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health. Arthritis Care Res. 1999;6:401-410.
11. Sutcliffe N, Clarke AE, Taylor R, et al. Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2001;40:37-47.
12. Dobkin PL, Fortin PR, Joseph L, et al. Psychosocial contributors to mental and physical health in patients with systemic lupus erythematosus. Arthritis Care Res. 1998;11:23-31.
13. Bae S, Hashimoto H, Karlson EW, et al. Variable effects of social support by race, economic status, and disease activity in systemic lupus erythematosus. J Rheumatol. 2001;28:1245-1251.
14. Ward MM, Lotstein DS, Bush TM, et al. Psychosocial correlates of morbidity in women with systemic lupus erythematosus. J Rheumatol. 1999;26:2153-2158.
15. McHorney CA, Ware JE, Raczek AE. The MOS 36-item Short-Form health survey (SF-36): II. Psychometric and clinical tests of validity measuring physical and mental health constructs. Med Care. 1993;31:247-263.
16. Wolf F. Health-status questionnaires. Rheum Dis Clin North Am. 1995;21:445-464.
17. Stoll T, Gordon C, Seifert B, et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol. 1997;24:1608-1614.
18. Thumboo J, Fong KY, Ng TP, et al. Validation of the MOS SF-36 for quality of life assessment in patients with systemic lupus erythematosus in Singapore. J Rheumatol. 1999;26:97-102.
19. Ware JE, Sherbourne CD. The MOS 36-item Short-Form health survey (SF-36). Med Care. 1992;30:473-483.
20. McHorney CA, Ware JE, Lu JFR, et al. The MOS 36-item Short-Form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32:40-66.
21. SPSS 10.0 for Windows. Chicago: SPSS Inc; 2000.
22. Ware JE, Kosinski M, Dewey JE. How to Score Version Two of the SF-36® Health Survey. Lincoln, RI: Quality Metric Inc; 2000.
23. Gordon C, Clarke AE. Quality of life and economic evaluation in SLE clinical trials. Lupus. 1999;8:645-654.
24. Alarcon GS, McGwin G Jr, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups. VII. Predictors of early mortality in the LUMINA cohort. Arthritis Care Res. 2001;45:191-202.
25. Sutcliffe N, Clarke AE, Farewell V, et al. The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology (Oxford). 1999;38:1130-1137.